Why guess when you could know? Gold Standard. Cardiac catheterization (Angiogram) Invasive Risks: Infection, hematoma, death

Similar documents
HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014

Optimizing CHF Therapy: The Role of Digoxin, Diuretics, and Aldosterone Antagonists

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Heart Failure Clinician Guide JANUARY 2018

Heart Failure Clinician Guide JANUARY 2016

Congestive Heart Failure: Outpatient Management

1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure?

Chronic. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Michael G. Shlipak, MD, MPH

Case 1. Case 2. What do you think about reducing or discontinuing some of the above now that his LVEF has normalized?

Difficult to Treat Hypertension

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF

Cardiovascular Clinical Practice Guideline Pilot Implementation

Evaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF<40%

HFpEF. April 26, 2018

Chronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology

CLINICAL PRACTICE GUIDELINE

Chronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.

LITERATURE REVIEW: HEART FAILURE. Chief Residents

Antialdosterone treatment in heart failure

MEDICAL MANAGEMENT OF PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION

Contemporary Management of Heart Failure. Keerthy K Narisetty, MD Comprehensive Heart Failure Management Program BHHI Primary Care Symposium

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 10/5/2015. Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center

Heart Failure. Dr. William Vosik. January, 2012

Heart Failure Background, recognition, diagnosis and management

Heart Failure A Team Approach Background, recognition, diagnosis and management

Management Strategies for Advanced Heart Failure

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.

Chronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 2/20/2017. Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center

Checklist for Treating Heart Failure. Alan M. Kaneshige MD, FACC, FASE Oklahoma Heart Institute

Outline. Chronic Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.

Summary/Key Points Introduction

Case Summary. Workshop Overview. Mr. M

Heart Failure. Jay Shavadia

was admitted to the Cardiology Service at the from Y /M /D to Y / M / D under the care of Dr..

Stable Angina: Indication for revascularization and best medical therapy

Akash Ghai MD, FACC February 27, No Disclosures

Improving Transition of Care in Congestive Heart Failure. Mark J. Gloth, DO, MBA. Vice President, Chief Medical Officer HCR ManorCare

State-of-the-Art Management of Chronic Systolic Heart Failure

Definition of Congestive Heart Failure

Neprilysin Inhibitor (Entresto ) Prior Authorization and Quantity Limit Program Summary

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Guideline-Directed Medical Therapy

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

The Failing Heart in Primary Care

I have no disclosures. Disclosures

Objectives. Outline 4/3/2014

Susan P. D Anna MSN, APRN BC February 14, 2019

Heart Failure: Guideline-Directed Management and Therapy

2016 Update to Heart Failure Clinical Practice Guidelines

Is it HF secondary to rheumatic heart disease???

Therapeutic Targets and Interventions

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies

HEART FAILURE: PHARMACOTHERAPY UPDATE

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:

Incidence. 4.8 million in the United States. 400,000 new cases/year. 20 million patients with asymptomatic LV dysfunction

Carol s View of a Cardiologist

LXIV: DRUGS: 4. RAS BLOCKADE

Background: Patient Adherence Challenges/Barriers

ARNI (Angiotensin Receptor blocker / Neprilysin Inhibitors [Sacubutril/Valsartan]) Heart Failure Medication Initiation and Titration

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept

Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set

Difficult Data Definitions and Scenario s

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD

Cardiorenal and Renocardiac Syndrome

Heart Failure Management Policy and Procedure Phase 1

A patient with decompensated HF

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)

Congestive Heart Failure or Heart Failure

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement

Pathophysiology: Heart Failure

Gina G. Mentzer, MD Cardiologist, Heart Failure & Transplant Advanced Integrated Medicine & Surgery (AIMS) Program for Heart Failure April 18 th,

CONCORD INTERNAL & PULMONARY MEDICINE CONGESTIVE HEART FAILURE PROTOCOL. Douglas G. Kelling, Jr., MD & C. Gismondi-Eagan, MD, FACP

New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0.

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Difficult to Control HTN: It is not all the same. Structured approach to evaluation and treatment

MITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT. Irene Frantzis P year, SGUL Sheba Medical Center

Updates in Diagnosis & Management of CHF

Module 1: Evidence-based Education for Health Care Professionals

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

HEART CONDITIONS IN SPORT

Miscellaneous Cardiology Topics pregnancy - congenital - myocarditis - pericardial disease. Pregnancy and Cardiovascular Disease MCQ

Assessment and Diagnosis of Heart Failure

The ACC Heart Failure Guidelines

Congestive Heart Failure 2015

Sara O. Weiss, MD Director, Heart Failure Services Virginia Mason Medical Center September 8, 2012

Translating Evidence Based Recommendations Into Practice

Heart Failure. Disclosures. Objectives: 8/28/2017. This is not a virus. It doesn t go away. none

Detailed Order Request Checklists for Cardiology

Transcription:

Why guess when you could know? Gold Standard Cardiac catheterization (Angiogram) Invasive Risks: Infection, hematoma, death

PCI decisions Number of vessels involved Surgeon experience level The anatomic complexity of the lesions Likelihood of complete revascularization How well-preserved left ventricular systolic function Low complexity coronary anatomy

WHO CRITERIA significant stenosis as 70% diameter narrowing, ( 50% for left main CAD) assessment of fractional flow reserve (FFR) 0.80 can also be considered to be significant

Indications for CABG CABG is the preferred treatment for: 1. Left main coronary artery 2. Disease of all three coronary vessels LAD,LCX and RCA 3. Diffuse disease not amenable to treatment with a PCI. The 2005 ACC/AHA guidelines: Also high-risk patients: severe ventricular dysfunction (i.e. low ejection fraction), or diabetes mellitus

Other indications large amount of potentially ischemic myocardium those who are not candidates for long-term dual antiplatelet therapy Previous failed prior PCI Patients with ischemic cardiac arrest Anatomically complex disease may also be considered for CABG.

The Cardiology Happy Meal BB ACEI Statin ASA/Antiplatelet Fix It All

The Happy Meal: Not so happy? I feel dizzy now I don t want to be on all these medications Phase II Cardiac Rehab

MI Complications Dressler's syndrome (Pericarditis) CHF Arrhythmia Left ventricular Aneurysm LV Thrombus

Complication

Prevention Diet, exercise for lipid lowering Stop smoking Treat HTN, DM Reduce inflammation Reduce stress

Heart Failure

What is missing? What is the dx? Coreg NTG Lisinopril Lasix Multaq

Growing problem one million Americans are admitted for heart failure per year...and up to 20% are readmitted within 30 days.

EXAM DOE, PND, orthopnea, rales Weight loss/gain, poor appetite S3, MR murmur, displaced PMI, HR JVD, HJR, pedal edema, ascites CXR (pulmonary edema) Decreased mentation Oliguria

MI Valve disease Causes Anemia Thyroid Toxins

CASE: 57 y/o male with low EF Stopped using CPAP gained weight s/p hip replacement Last year had EF of 62% now 36% holter showed poor rate control Cardiomyopathy. Should ve had the ablation Should ve kept using the CPAP If hip hurts, swim!

NYHA HF Classification

Can have both

How do we acutely treat CHF? L=Lasix Pressure = BiPap M=Morphine N=Nitrates O=Oxygen P = Pressure

Patients with LVEF 40% or less with symptoms or prior symptoms, unless contraindicated, to reduce morbidity and mortality ACEI Asymptomatic patients with LVEF 35% or less Common ACEI: Lisinopril, Ramipril, Enalapril Check potassium, serum creatinine, and blood pressure within one week of initiation or dosage increase in the elderly, and within one to two weeks of initiation or dose

If fluid retention Loops preferred, but thiazides can be considered for patients with hypertension and mild fluid retention. Diuretics Furosemide: initial 20 to 40 mg once or twice daily, max total daily dose 600 mg Bumetanide: initial 0.5 to 1 mg once or twice daily, max total daily dose 10 mg Torsemide: initial 10 to 20 mg once daily, max total daily dose 200 mg

Beta blockers Stable patients with LVEF 40% or less with sx If hypotension occurs, separate betablocker from other hypotensive agents (e.g., ACEI), or decrease diuretic dose Don t stop abruptly Use Metoprolol Succinate (Toprol XL, Coreg)

Special Populations Use an aldosterone antagonist for patients with class II to IV heart failure...if CrCl is > 30 ml/min and potassium is < 5 meq/l. Consider adding hydralazine plus isosorbide dinitrate in African Americans with class III or IV symptomatic heart failure.

Don t make it worse NSAIDS Glitazones Diltiazem Verapamil Procardia Sotolol Dronaderone

Fight or flight Rubber band theory Heart fails = stress = catecholamine release RAAS activates Retain sodium, heart rate goes up Increased sodium = increased fluids = more failure

Things the patient can fix Lifestyle, diet Things we can fix Anemia Arrhythmia HTN Infection Thyroid disease

Treatment Less fluid in More fluid out = Loop diuretics Low salt (2 g max/d) ACEI Cardiac Rehabilitation Patient education

Cardiomyopathies

Dilated 95% (floppy) Hypertrophic 4% (bulky) Restrictive 1% (squished)

Dilated: Floppy Heart Mechanism=Bad Muscle Function Males Idiopathic 30% Drugs (Cocaine/Adriamycin) Thyroid (hypo or hyper) Peripartum Infection CHF = SOB/Rales and JVD/S3

HOCM When is it usually diagnosed?

HOCM

Something is in the way. Syncope Chest pain DOE Dyspnea at rest Palpitations MR S4 S3

HOCM Clues DOE in a young patient Athlete syncopal during exercise Palpitations, orthopnea

ECG Findings Which would you rather have as your wine glass?

Restrictive Cardiomyopathy I have CHF symptoms, with a normal size heart.

Heart is normal size, but is too stiff to relax Restrictive Cardiomyopathy Least common cause of cardiomyopathy Amyloidosis or scarring most common cause, sarcoidosis, scleroderma About 70% of people die within 5 years after symptoms begin unless heart transplant

Symptomatic treatment usually not helpful Treatment Hemachromatosis, the exception (ir0n studies) Cardiac MRI in addition

Jennifercarlquist@yahoo.com